Operating Lease, Right-of-Use Asset of Carisma Therapeutics Inc. from 01 Jan 2019 to 30 Sep 2025

Taxonomy & unit
us-gaap: USD
Description
Amount of lessee's right to use underlying asset under operating lease.
Summary
Carisma Therapeutics Inc. quarterly Operating Lease, Right-of-Use Asset in USD history and change rate from 01 Jan 2019 to 30 Sep 2025.
  • Carisma Therapeutics Inc. Operating Lease, Right-of-Use Asset for the quarter ending 30 Sep 2025 was $684,000, a 71% decline year-over-year.
Source SEC data
View on sec.gov
Operating Lease, Right-of-Use Asset, Quarterly (USD)
Operating Lease, Right-of-Use Asset, YoY Quarterly Change (%)

Carisma Therapeutics Inc. Quarterly Operating Lease, Right-of-Use Asset (USD)

Period Value YoY Chg Change % Date Report Filed Fiscal Year Fiscal Period
Q3 2025 $684,000 -$1,638,000 -71% 30 Sep 2025 10-Q 12 Nov 2025 2025 Q3
Q2 2025 $717,000 -$1,228,000 -63% 30 Jun 2025 10-Q 07 Aug 2025 2025 Q2
Q1 2025 $1,999,000 -$3,151,000 -61% 31 Mar 2025 10-Q 13 May 2025 2025 Q1
Q4 2024 $2,040,000 -$133,000 -6.1% 31 Dec 2024 10-Q 12 Nov 2025 2025 Q3
Q3 2024 $2,322,000 +$658,000 +40% 30 Sep 2024 10-Q 07 Nov 2024 2024 Q3
Q2 2024 $1,945,000 -$1,102,000 -36% 30 Jun 2024 10-Q 08 Aug 2024 2024 Q2
Q1 2024 $5,150,000 +$1,657,000 +47% 31 Mar 2024 10-Q 09 May 2024 2024 Q1
Q4 2023 $2,173,000 -$2,649,000 -55% 31 Dec 2023 10-K 31 Mar 2025 2024 FY
Q3 2023 $1,664,000 +$1,664,000 30 Sep 2023 10-Q 09 Nov 2023 2023 Q3
Q2 2023 $3,047,000 +$3,005,300 +7207% 30 Jun 2023 10-Q 10 Aug 2023 2023 Q2
Q1 2023 $3,493,000 +$3,393,000 +3393% 31 Mar 2023 10-Q 11 May 2023 2023 Q1
Q4 2022 $4,822,000 +$4,698,700 +3811% 31 Dec 2022 10-K 01 Apr 2024 2023 FY
Q3 2022 $0 30 Sep 2022 10-Q 07 Nov 2022 2022 Q3
Q2 2022 $41,700 30 Jun 2022 10-Q/A 25 Aug 2022 2022 Q2
Q1 2022 $100,000 31 Mar 2022 10-Q 09 May 2022 2022 Q1
Q4 2021 $123,300 31 Dec 2021 10-K 28 Feb 2023 2022 FY
Q4 2018 $200,000 01 Jan 2019 10-K 15 Mar 2021 2020 FY
* An asterisk sign (*) next to the value indicates that the value is likely invalid.